Cytokast 50mg Injection
Rx RequiredSalt Composition: Cisplatin Injection IP
Expiry Date: 01/2028
Price on Request
Inclusive of all taxes
1 Injection
About The Product
Advanced Cancer of the bladder, Advanced Cancer of the Testicles
null
Description
Cytokast 50mg Injection is a doctor's prescribed anticancer injection that is used to multiple types of cancers including Blood Cancers, Breast Cancer, Ovarian Cancer and Neuroblastoma.Cytokast 50mg Injection contains cyclophosphamide as its active salt. It inhibits cancer cell replication and lead to cancer cell death, primarily in proliferating cells.
As a result, cancer cell growth stops.
Common Side Effects
- Cytokast 50mg Injection is a chemical salt based anticancer injection.
- Its salt in reaction with the body leads to numerous side effects like any other chemical medication.Symptoms may vary from mild to severe.
- If these side effects remain for longer period of time, consult your doctor immediately. ● Hair loss ● Mouth Sores ● Nausea ● Weakness ● Low Red, White and Platelets Blood Cell Count ● Fluid Retention ● Muscle Pain ● Nail Change ● Febrile Nutropenia ● Allergic Reactions ● Peripheral Neuropathy ● Liver Toxicity ● Painful Urination ● Infection Risk ● Pneumonitis ● Secondary Cancer or Diseases
Dosage And Administration
- Cytokast 50mg Injection is administered intravenously (In Veins) by a doctor or an experienced nurse.
- It is advice not to self administer the injection on your own.
- For personalized dosage ask your doctor about the same.
- As Dosage is entirely based on the body surface area, type of cancer, its stage as well as patient's overall health.
Mechanism Of Action
Cytokast 50mg contains 50mg of cyclophosphamide as its active salt. Cyclophosphamide is a prodrug activated in the liver by cytochrome P450 enzymes to its activated and functional form.
This causes cross-links that inhibit replication and lead to cancer cell death, primarily in proliferating cells.As a result, cancer cell growth stops.
Safety Advice
Faqs
Cytokast Injection is used to treat multiple cancers including lymphomas, leukemias, breast cancer, ovarian cancer, Neuroblastoma, multiple myeloma, and sarcomas.
References
• Sharata, E. E., Bakry, T., Atta, H.
G., Mohammed, H. A., Diab, N.
S., Atef, R. A., ... & Hemeida, R.
A. (2025).
Molecular mechanisms underlying cyclophosphamide-induced ovarian injury and protective strategies. Naunyn-Schmiedeberg's archives of pharmacology, 1-35. • Ge, Y., Domschke, C., Stoiber, N., Schott, S., Heil, J., Rom, J., ... & Schuetz, F.
(2012). Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.
Cancer immunology, immunotherapy, 61(3), 353-362. • Emadi, A., Jones, R. J., & Brodsky, R.
A. (2009).
Cyclophosphamide and cancer: golden anniversary. Nature reviews Clinical oncology, 6(11), 638-647. • Voelcker, G.
(2020). The mechanism of action of cyclophosphamide and its consequences for the development of a new generation of oxazaphosphorine cytostatics.
Scientia pharmaceutica, 88(4), 42.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75 "Venika Choudhary")
.png%3FupdatedAt%3D1763121181806&w=128&q=75 "Dr. Aditya Sarin")
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
